Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver DiseaseBenedikt Simbrunner, Diana Julie Leeming, Ida Falk Villesen et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 9
The Vasopressin Biomarker Copeptin Is Linked to Systemic Inflammation and Refines Prognostication in Decompensated CirrhosisLukas Hartl, Thomas Reiberger, Marlene Hintersteininger et al.|Clinical Gastroenterology and Hepatology|2025Cited by 6
Diagnostic and Clinical Implications of High Spleen‐To‐Liver Stiffness Ratio in <scp>MASH</scp> —A Prospective, Comparative StudyChristian Sebesta, David Bauer, Mathias Jachs et al.|Liver International|2025Cited by 5
Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute DecompensationLucie Simonis, Georg Semmler, Thomas Reiberger et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 5
Smoking Aggravates Inflammation, Fibrogenesis, Angiogenesis and Cancer Risk in Patients With CirrhosisNina Dominik, Benedikt Hofer, Benedikt Simbrunner et al.|Liver International|2025Cited by 4